JANNEY DANIEL — SEC Form 4 filings

SEC reporting owner CIK 1198325. 5 Form 4 filings on record with FilingPulse; latest filed 2026-09-16.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-07-01 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Krystal Biotech, Inc. (KRYS)Director522 legs · 71,964 sh · $19,402,2076

Form 4 filings — JANNEY DANIEL

FiledFormIssuerReported transactionsSource
2026-09-164Krystal Biotech, Inc. (KRYS)Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0EDGAR
2026-03-034Krystal Biotech, Inc. (KRYS)Sale (S): 9,430 @ $275.45 · Sale (S): 2,373 @ $276.17EDGAR
2026-02-264Krystal Biotech, Inc. (KRYS)Option exercise (M): 37,895 @ $2.46 · Sale (S): 569 @ $262.91 · Sale (S): 1,733 @ $264.12 · Sale (S): 3,557 @ $265.08 · Sale (S): 8,986 @ $266.18 · Sale (S): 11,673 @ $266.97 · +16 moreEDGAR
2025-06-304Krystal Biotech, Inc. (KRYS)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2024-07-014Krystal Biotech, Inc. (KRYS)Grant/award (A): 5,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1198325 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →